Stay updated on Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:18:20.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the study's two-year recurrence free survival (RFS) for high-risk liver cancer patients following liver transplantation. This change may reflect new data or findings related to the effectiveness of sorafenib in preventing cancer recurrence in this patient population.
    Difference
    0.1%
    Check dated 2024-06-06T14:51:18.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    44%
    Check dated 2024-05-22T21:34:33.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:43:51.000Z thumbnail image

Stay in the know with updates to Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.